HF 4504 – MinnesotaStatus: Inactive / Dead
Year Introduced: 2022
Prescription drug price transparency provisions modified. Proposed changes: (13) if the prescription drug was acquired by the manufacturer during the previous
12-month period, all of the following information:
(i) price at acquisition;
(ii) price in the calendar year prior to acquisition;
(iii) name of the company from which the drug was acquired;
(iv) date of acquisition; and
(v) acquisition price.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
No items found